Aarkstore - The Chinese Pharmaceuticals Market to 2024

1
Aarkstore - The Chinese Pharmaceuticals Market
to 2024
Category Healthcare
2
Aarkstore - The Chinese Pharmaceuticals Market to
2024
3
Summary

•   The OTC drugs market in China was characterised
  by a late start, but fast growth, along with huge
  potential in comparison to that of the mature OTC
  markets in many western countries. Your company
  should be benefiting from this market access
  and this is only the OTC market what has the
  growth been throughout the whole Chinese pharma
  sector? This report will tell you.Chinas
  pharmaceutical sales growth is based on economic
  growth in the country This has resulted in
  increased healthcare expenditure internally, and
  increased manufacture and export. Increasing
  urbanisation, disposable income, aging
  population, health education, lifestyle diseases
  and government investments and initiatives for
  healthcare infrastructure improvement have helped
  the market growth considerably. Have you captured
  enough of the Chinese market?

4
Annually, an average of 190 is spent for the
treatment of diabetes, per patient, in China. By
2030, in China, diabetes is expected to cost Yuan
173.4bn (28 bn) a year. China is expected to top
the worlds diabetes tables both in terms of
sheer numbers and population prevalence. This is
true across a range of complaints and products
types your company must capture a segment of
this market TODAY.Anti-Counterfeiting and
anti-corruption How the Chinese market is
changingCounterfeit drugs are successfully
introduced in to the lengthy and complicated
delivery chain because of the highly fragmented
nature of the market. A lack of regular
inspections by any recognised drug enforcement /
regulatory bodies, again due to the highly
fragmented nature of production, allows
counterfeit / poor quality drugs into the Chinese
pharma market. Moreover, wide spread corruption
also helps the distribution of counterfeit drugs.
What are the Chinese regulators, and the global
manufacturers doing to change this? Find out in
this unique report.  
5
Table of Contents

• Executive Summary  1.1. Chinese Pharmaceutical
  Market Review  1.2. Chapter Breakdown  1.3.
  Research and Analysis Methods  2. Drivers
  Restraints of the Chinese Pharmaceutical
  Market  2.1 An Ageing Population will drive
  pharmaceutical market growth in China  2.2
  Increase in Chinese urbanisation  2.3 Increase
  in Healthcare expenditure will increase drug
  demand in China  2.4 Government policies and
  changing environment for MNCs in China  2.5
  Increased demand for improved drug quality 

6
List Of Tables

• Table 2.1.1 Percentage of Chinese population
  aged 60 and over / 65 and over in 2000, 2011
  2016  Table 2.1.2 Health spending in China,
  India and the US, 2009 2011 (/p/a percentage
  change)  Table 2.1.3 Total Health Expenditure
  (as of GDP) Selected Countries 2004 to
  2011  Table 2.1.4 Life expectancy Selected
  Countries 2004 to 2011  Table 2.2.1 Medical
  Coverage for Rural / Urban inhabitants in China
  2006 / 2009 (million people)  Table 2.2.2
  Major cities in China by population
  (2011)  Table 2.3.1 Chinas Health Care
  Expenditure Per Capita 2003-2011  Table 2.6.1
  Key New Drugs on the 2012 Essential Drugs List

7
List Of Figures

• Figure 2.1.1 China population growth
  trend 1950-2013Figure 2.1.2 Projected
  comparison of Chinas population vs. other
  heavily populated countries 2016 (million
  people)Figure 2.1.3 Chinas Age distribution
  2001 to 2011Figure 2.1.4 Life expectancy in
  ChinaFigure 2.2.1 Chinas Rural and Urban
  population from 1990 to 2025 Billion
  PeopleFigure 2.2.2 Chinas Urbanisation Rate
  1990-2025 ()Figure 2.2.3 Per Capita
  Disposable Income Figure 2.3.1 China GDP
  growth trend (2004 2012)Figure 2.3.2 Chinas
  total health expenditure (as of GDP) 2004 to
  2011Figure 2.3.3 China healthcare expenditure
  per capita growth trend (2003 2011)
•  

8
Related Reports

• Generic Drugs Market in Japan 2015-2019
• Lung Cancer-Global API Manufacturers, Marketed
  and Phase III Drugs Landscape, 2015
• Metastatic Brain Tumor-Global API Manufacturers,
  Marketed and Phase III Drugs Landscape, 2015
• Lupus Erythematosus-Global API Manufacturers,
  Marketed and Phase III Drugs Landscape, 2015
• Metastatic Breast Cancer-Global API
  Manufacturers, Marketed and Phase III Drugs
  Landscape, 2015

9
Related Reports

• Malaria-Global API Manufacturers, Marketed and
  Phase III Drugs Landscape, 2015
• Metastatic Colorectal Cancer-Global API
  Manufacturers, Marketed and Phase III Drugs
  Landscape, 2015
• Melanoma-Global API Manufacturers, Marketed and
  Phase III Drugs Landscape, 2015
• Metastatic Hormone Refractory (Castration
  Resistant, Androgen-Independent) Prostate
  Cancer-Global API Manufacturers, Marketed and
  Phase III Drugs Landscape, 2015
• Pharmaceuticals Healthcare Market Research
  Reports

10
The Chinese Pharmaceuticals Market to
2024 Published Sep 2014 160 Pages Chinas
pharmaceutical sales growth is based on economic
growth in the country This has resulted in
increased healthcare expenditure internally, and
increased manufacture and export.
Format Price
PDF 1799
Site License 3599
Enterprise Wide Licence 8499
11
Contact Us

• Office
• Office No. - 809, 8th Floor,
• B-Wing, Mahaavir Icon, 
• Plot No.- 89 90, Sector-15,
• CBD-Belapur, Navi Mumbai 400614, 
• Maharashtra, India.
• Telefax No 91 22 4127 6660
• 24/7 Online Support 91 9987295242
• General Inquiries 91 - 22 2756 4953

• You Can Visit
• http//www.aarkstore.com
• OR Mail us at
• contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news